A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors Solid Tumors Recruiting Phase 1 / Phase 2 2026-09-10 NCT07231211 Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer Locally Advanced Gastric or Gastroesophageal Junction Cancer Recruiting Phase 3 2026-05-13 NCT07522151 Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma Not yet recruiting Phase 2 2026-04-28 NCT07554768 Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm Not yet recruiting Phase 2 2026-04-28 NCT07543783 A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer Advanced Cervical Cancer Recruiting Phase 3 2026-04-15 NCT07168200 Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC) Small Cell Lung Cancer Extensive Stage Recruiting Phase 2 2026-02-09 NCT06610734 Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer. MSS Metastatic Colorectal Cancer Recruiting Not applicable 2024-09-25 NCT06613113 A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients Non-squamous Non-small Cell Lung Cancer Not yet recruiting Phase 2 / Phase 3 2024-03-28 NCT06335355